Methyl Palmitate, a Potent Angiotensin Converting Enzyme Inhibitor, Attenuates Vascular Remodeling in L-N G -Nitro Arginine Methyl Ester-Induced Hypertensive Wistar Rat Models
Journal of Vascular Research · 09.03.2026 · 63 (4) · 231-243
DOI: 10.1159/000551278 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Vascular Research, online erschienen am 09.03.2026. Verfasst von Ashwini Rao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme Inhibitors, Hypertension, NG-Nitroarginine Methyl Ester, Palmitates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Angiotensin converting enzyme (ACE) regulates blood pressure via the renin-angiotensin and bradykinin systems. Though synthetic ACE inhibitors are more effective, they pose several side effects. Methyl palmitate (MP), a natural fatty acid methyl ester with cytoprotective, antioxidant, anti-inflammatory, and vasodilatory properties, is not explored for its ACE inhibitory or antihypertensive potential. This study aimed to investigate the in vitro ACE inhibition of MP and its effect on L-NG-Nitro Arginine Methyl Ester (L-NAME)-induced hypertensive male Wistar rats.
Methods
An in vitro ACE inhibition assay was conducted to compare the inhibition potency of MP with that of lisinopril. Male Wistar rats (n = 35, 7 per group) were grouped into control, disease control, and treatment groups receiving 100, 150, or 200 mg/kg/day of MP for 21 days each. Blood pressure, serum ACE activity, malondialdehyde (MDA), and nitric oxide (NO) levels in kidney tissue homogenate, and thoracic aorta histopathology were assessed.
Results
MP inhibited ACE by 61.05% at 5 µm, exceeding lisinopril’s 41.67%. High-dose MP significantly reduced serum ACE and MDA levels, while increasing NO (p < 0.001). Histopathology revealed near-normal vasculature, although changes in blood pressure were not statistically significant (p > 0.05).
Conclusion
MP demonstrates strong natural ACE inhibition, antioxidant, and vascular protective effects, supporting further research for therapeutic optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
- Department of Biochemistry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India, padmanabha.udupa@manipal.edu.
- Centre for Cardiovascular Pharmacology, Department of Pharmacology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
Zitieren
APA
Rao, A., Udupa, P., Rhea Lewis, C., & Yelleti, G. (2026). Methyl Palmitate, a Potent Angiotensin Converting Enzyme Inhibitor, Attenuates Vascular Remodeling in L-N G -Nitro Arginine Methyl Ester-Induced Hypertensive Wistar Rat Models. Journal of Vascular Research, 63(4), 231-243. https://doi.org/10.1159/000551278
Vancouver
Rao A, Udupa P, Rhea Lewis C, Yelleti G. Methyl Palmitate, a Potent Angiotensin Converting Enzyme Inhibitor, Attenuates Vascular Remodeling in L-N G -Nitro Arginine Methyl Ester-Induced Hypertensive Wistar Rat Models. Journal of Vascular Research. 2026;63(4):231-243. doi:10.1159/000551278
BibTeX
@article{Rao2026,
author = {Rao, Ashwini and Udupa, Padmanabha and Rhea Lewis, Cheryl and Yelleti, Geethika},
title = {Methyl Palmitate, a Potent Angiotensin Converting Enzyme Inhibitor, Attenuates Vascular Remodeling in L-N G -Nitro Arginine Methyl Ester-Induced Hypertensive Wistar Rat Models},
journal = {Journal of Vascular Research},
year = {2026},
volume = {63},
number = {4},
pages = {231--243},
doi = {10.1159/000551278}
}
EUVIMED